Skip to content

Single Dose Morphine and Fentanyl Added to Intrathecal Mixture on Orthopedics Patients With Undiagnosed Obstructive Sleep Apnea

Randomized Comparison Study of Single Dose Morphine and Fentanyl Added to Intrathecal Mixture on Orthopedics Patients With Undiagnosed Obstructive Sleep Apnea

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02014714
Enrollment
40
Registered
2013-12-18
Start date
2013-12-31
Completion date
2014-06-30
Last updated
2013-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea of Adult

Brief summary

Obstructive Sleep Apnea (OSA) is a common clinical problem with a reported prevalence of 2% to 4% in the general population. The incidence was double on patients who had a diagnosis of OSA going for orthopedics surgery. Little literature composed mostly of case reports or small retrospective case-control studies exist examining the use of intrathecal opioids on outcomes in OSA patients is inconclusive. The primary objective of this study is to compare the post operative respiratory effect after single dose intrathecal morphine and intrathecal fentanyl on orthopedics patients who suspected or undiagnosed obstructive sleep apnea. Hypotheses Undiagnosed OSA patients who received intrathecal morphine are more likely to have respiratory events post-operatively.

Detailed description

This is a prospective, randomized study to compare the post operative respiratory effect after single dose intrathecal morphine (0.1mg) and intrathecal fentanyl (40mcg) on orthopedics patients who suspected or undiagnosed obstructive sleep apnea.

Interventions

DRUGMorphine

Drug: Morphine Depending on the randomization schedule, 0.1mg of morphine or will be added to the intrathecal mixture.

DRUGFentanyl

Drug: Fentanyl 40mcg Depending on the randomization schedule, 40μg of fentanyl will be added to the intrathecal mixture.

Sponsors

University of Malaya
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age ≥ 18 2. ASA I - II 3. Patients who admitted for orthopedic surgery and consented for regional anesthesia 4. STOP - BANG score ≥ 5

Exclusion criteria

1. Refused to give informed consent 2. Previous diagnosis and treatment of OSA or any sleep-related breathing disorder 3. Allergic to morphine / fentanyl / Local anesthetic 4. Contra-indicated for regional anesthesia 5. Pregnant woman 6. Contraindication to either of the oral analgesia as in protocol

Design outcomes

Primary

MeasureTime frameDescription
Respiratory Rate (RR)72 hours post operativelyThe end point of the study is to assess the respiratory rate (RR) within 72 hours post-operatively in both arms of the patients.
Heart Rate (HR)72 hours post-operativeThe end point of the study is to assess the heart rate (HR) within 72 hours post-operatively in both arms of the patients.
Oxygen Desaturation Index (ODI)72 hours post-operativeThe end point of the study is to assess the Oxygen Desaturation Index (ODI) within 72 hours post-operatively in both arms of the patients.

Countries

Malaysia

Contacts

Primary ContactWang Chew Yin
wangcy1836@gmail.com60379494422

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026